|
Q1 2024
|
1 |
0 |
|
13F-HR
|
5/7/2024 |
000163305524000003 |
|
Q4 2023
|
25 |
17,441 |
BSX, TMO, AXNX, ELV
|
13F-HR
|
2/14/2024 |
000163305524000002 |
|
Q3 2023
|
43 |
111,347 |
BMRN, TMO, BRKR, AZN
|
13F-HR
|
11/14/2023 |
000163305523000008 |
|
Q2 2023
|
34 |
114,544 |
SPY puts, BMRN calls, LH, CI
|
13F-HR
|
8/14/2023 |
000163305523000007 |
|
Q1 2023
|
50 |
194,673 |
BMRN, BDX, ELV, SBRA
|
13F-HR
|
5/15/2023 |
000163305523000006 |
|
Q4 2022
|
55 |
246,253 |
INVACARE CORP, LH, CI, MRK
|
13F-HR
|
2/14/2023 |
000163305523000002 |
|
Q3 2022
|
49 |
307,049 |
INVACARE CORP, LH, HUM, TAK
|
13F-HR
|
11/14/2022 |
000163305522000007 |
|
Q2 2022
|
50 |
285,049 |
INVACARE CORP, QGEN, BSX, AVTR
|
13F-HR
|
8/15/2022 |
000163305522000006 |
|
Q1 2022
|
63 |
379,607 |
INVACARE CORP, SPY puts, CNC, LH
|
13F-HR
|
5/16/2022 |
000163305522000005 |
|
Q4 2021
|
68 |
414,302 |
INVACARE CORP, SPY puts, SNY, LH
|
13F-HR
|
2/14/2022 |
000163305522000002 |
|
Q3 2021
|
53 |
439,127 |
SPY puts, INVACARE CORP, TRIL calls, ABBV
|
13F-HR
|
11/15/2021 |
000163305521000008 |
|
Q2 2021
|
57 |
363,842 |
INVACARE CORP, LH, CI, ICLR
|
RESTATEMENT
|
8/27/2021 |
000163305521000007 |
|
Q1 2021
|
61 |
383,538 |
KIDS, INVACARE CORP, ATNM calls, BMY
|
13F-HR
|
5/17/2021 |
000163305521000004 |
|
Q4 2020
|
52 |
277,286 |
OXFORD IMMUNOTEC GLOBAL PLC, BDX, BMY, TRIL
|
13F-HR
|
2/16/2021 |
000163305521000002 |
|
Q3 2020
|
60 |
338,154 |
SPY puts, BMY, OXFORD IMMUNOTEC GLOBAL PLC, EHC
|
13F-HR
|
11/16/2020 |
000163305520000005 |
|
Q2 2020
|
56 |
1,824,008 |
IWN puts, SPY puts, OXFORD IMMUNOTEC GLOBAL PLC, EVOLENT HEALTH INC
|
13F-HR
|
8/14/2020 |
000163305520000003 |
|
Q1 2020
|
51 |
220,672 |
SNY, PFE, HOLX, SIBN
|
13F-HR
|
5/15/2020 |
000163305520000002 |
|
Q4 2019
|
54 |
317,448 |
BMY, ELV, ZBH, OXFORD IMMUNOTEC GLOBAL PLC
|
13F-HR
|
2/14/2020 |
000163305520000001 |
|
Q3 2019
|
49 |
278,635 |
RCM, ZBH, SPY puts, HCA
|
RESTATEMENT
|
11/25/2019 |
000163305519000007 |
|
Q2 2019
|
50 |
253,641 |
TAK, LH, ZBH, WMGI
|
13F-HR
|
8/14/2019 |
000163305519000005 |
|
Q1 2019
|
70 |
252,937 |
BMY, IIN, ICLR, VCRA
|
13F-HR
|
5/15/2019 |
000163305519000002 |
|
Q4 2018
|
48 |
189,197 |
AGN, CI, ZBH, CELG
|
13F-HR
|
2/14/2019 |
000163305519000001 |
|
Q3 2018
|
73 |
224,793 |
CI, SHPG, AGN, TVTY
|
13F-HR
|
11/14/2018 |
000163305518000004 |
|
Q2 2018
|
65 |
230,616 |
AGN, MRK, ABT, SHPG
|
13F-HR
|
8/14/2018 |
000163305518000003 |
|
Q1 2018
|
69 |
267,700 |
AGN, ABT, JNJ, MDT
|
13F-HR
|
5/15/2018 |
000163305518000002 |
|
Q4 2017
|
75 |
327,171 |
DVA, WBA, AGN, SBRA
|
13F-HR
|
2/14/2018 |
000163305518000001 |
|
Q3 2017
|
85 |
330,067 |
DVA, BIIB, OXFORD IMMUNOTEC GLOBAL PLC, SBRA
|
13F-HR
|
11/14/2017 |
000163305517000010 |
|
Q2 2017
|
92 |
353,664 |
TMO, UHS, OXFORD IMMUNOTEC GLOBAL PLC, ABT
|
13F-HR
|
8/14/2017 |
000163305517000008 |
|
Q1 2017
|
88 |
311,018 |
ABT, BDX, UHS, SHPG
|
13F-HR
|
5/15/2017 |
000163305517000004 |
|
Q4 2016
|
73 |
242,000 |
SHPG, EHC, STJ, ABT
|
13F-HR
|
2/15/2017 |
000163305517000002 |
|
Q3 2016
|
96 |
269,800 |
SHPG, AGN, ABT, EVHC
|
13F-HR
|
11/15/2016 |
000163305516000012 |
|
Q2 2016
|
88 |
299,166 |
AGN, SHPG, MNK, EHC
|
13F-HR
|
8/15/2016 |
000163305516000011 |
|
Q1 2016
|
86 |
308,678 |
TEVA, MNK, EHC, AET
|
13F-HR
|
5/16/2016 |
000163305516000009 |
|
Q4 2015
|
77 |
299,039 |
TEVA, MNK, ZBH, EHC
|
13F-HR
|
2/16/2016 |
000163305516000008 |
|
Q3 2015
|
77 |
299,508 |
STJ, TMO, BDX, TEVA
|
13F-HR
|
11/16/2015 |
000163305515000006 |
|
Q2 2015
|
93 |
338,867 |
BDX, AGN, LH, TMO
|
13F-HR
|
8/14/2015 |
000163305515000005 |
|
Q1 2015
|
96 |
302,675 |
GMED, ACTAVIS PLC, TMO, BDX
|
13F-HR
|
5/15/2015 |
000163305515000004 |
|
Q4 2014
|
87 |
254,880 |
TMO, BDX, ACTAVIS PLC, UHS
|
13F-HR
|
2/17/2015 |
000163305515000001 |